Skip to content

Clinical trials

Completed Phase 3 Urinary Bladder, Overactive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Phase: Phase 3 Status: Completed Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20048
20051
20063
20076
20088
20097
20104
20124
20135
20143
20153
20163
20183
20192
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc14
Allergan7
Pfizer7
Astellas Pharma Europe B.V.4
Urovant Sciences GmbH4
APOGEPHA Arzneimittel GmbH2
Astellas Pharma Europe Ltd.2
CHU de Quebec-Universite Laval2
Duramed Research2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive70
Urinary Incontinence23
Urinary Incontinence, Urge13
Urologic Diseases5
Lower Urinary Tract Symptoms3
Nocturia3
Prostatic Hyperplasia2
Urinary Bladder Diseases2
Multiple Sclerosis1
Parkinson Disease1

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.